Associate Professor of Dermatology, Yale University
Dermatology
Dr. Jeffrey S. Dover, MD
|
|
Give Review
Jeffrey S. Dover, MD works in the field of Dermatology. He received 8 awards: "America's Top Doctors", "Boston Magazine", "Boston Now Newspaper", "Boston Herald", "Fellow (FAAD)", "Fellow (FASDS)", "Super Doctor" and "Top MD". Doctor Jeffrey S. Dover, MD is also a published doctor. He has 74 paper published. The most recent paper is: Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes. He accepts all Medicare patients.
Publications
- Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes.
- Comparison of different technologies for noninvasive Skin tightening.
- Foreseeing the future of Skin tightening.
- Multicenter Prospective Cohort Study of the Incidence of Adverse Events Associated With Cosmetic Dermatologic Procedures: Lasers, Energy Devices, and Injectable Neurot...
- Successful Treatment of Disfiguring Hemosiderin-Containing Hyperpigmentation With the Q-Switched 650-nm Wavelength Laser.
- Using Checklists to Minimize Complications From Laser/Light Procedures.
- Use of Hyaluronidase in Patients With Bee Allergy.
- High-intensity focused ultrasound for the reduction of subcutaneous adipose tissue using multiple treatment techniques.
- Long-Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36-Month, Multicenter, Open-Label Extension Study.
- Fractionated ablative carbon dioxide laser for the treatment of rhinophyma.
- American society for dermatologic surgery dermatologic surgery drug and device nomenclature recommendations.
- How to prepare patients for ablative laser procedures.
- Combined treatment for facial rejuvenation using an optimized pulsed light source followed by a fractional non-ablative laser.
- Abbreviations for Device Names: A Proposed Methodology With Specific Examples.
- Evaluating facial pores and Skin texture after low-energy nonablative fractional 1440-nm laser treatments.
- A Randomized, Controlled Trial of Four Ablative Fractionated Lasers for PhotoAging: A Quadrant Study.
- A small study of the relationship between abobotulinum toxin a concentration and forehead wrinkle reduction.
- Recommendations and current practices for the reconstitution and storage of botulinum toxin type A.
- Two cases of herpes zoster appearing after botulinum toxin type a injections.
- Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ultrasound device for noninvasive body sculpting.
- To ablate or not: a proposal regarding nomenclature.
- Should we use light-emitting diode photomodulation to minimize radiation-induced Dermatitis?
- Fractional laser resurfacing: why all the fuss?
- Predicting migraine responsiveness to botulinum toxin type A injections.
- Commentary: the evolving role of photodynamic therapy for the treatment of photoaged Skin.
- Tissue tightening technologies.
- The filler revolution: a six-year retrospective.
- Review of the efficacy, durability, and safety data of two nonanimal stabilized hyaluronic acid fillers from a prospective, randomized, comparative, multicenter study.
- Effective treatment of psychotropic drug-induced facial hyperpigmentation with a 755-nm Q-switched alexandrite laser.
- Unipolar versus bipolar radiofrequency treatment of rhytides and laxity using a mobile painless delivery method.
- The spectrum of laser Skin resurfacing: nonablative, fractional, and ablative laser resurfacing.
- Plasma Skin regeneration technology.
- Management of complications and sequelae with temporary injectable fillers.
- Nonablative tissue remodeling and photorejuvenation.
- Evaluation of the 1,540-nm Erbium:Glass Laser in the Treatment of Inflammatory Facial Acne.
- Comparison of stacked pulses versus double-pass treatments of facial acne with a 1,450-nm laser.
- A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of latera...
- A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial eryth...
- Evaluation of plasma Skin regeneration technology in low-energy full-facial rejuvenation.
- Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2.
- Successful treatment of a widespread inflammatory verrucous epidermal nevus with etanercept.
- Patient satisfaction and reported long-term therapeutic efficacy associated with 1,320 nm Nd:YAG laser treatment of acne scarring and photoAging.
- A quality rating scale for aesthetic surgical procedures.
- Clinical effect of a single pulsed dye laser treatment of fresh surgical scars: randomized controlled trial.
- Complications of laser dermatologic surgery.
- Adverse event reporting for botulinum toxin type A.
- Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoAging.
- Bacterial sterility of stored nonanimal stabilized hyaluronic acid-based cutaneous filler.
- Low-level laser therapy for wound healing: mechanism and efficacy.
- Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytides.
- Effect of volume and concentration on the diffusion of botulinum exotoxin A.
- Clinical evaluation of enhanced nonablative Skin rejuvenation using a combination of a 532 and a 1,064 nm laser.
- A prospective survey of patient experiences after laser Skin resurfacing: results from 2 1/2 years of follow-up.
- Energy delivery devices for cutaneous remodeling: lasers, lights, and radio waves.
- Clinically significant facial edema after extensive treatment with purpura-free pulsed-dye laser.
- Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura thre...
- Why make patients exercise facial muscles for 4 hours after botulinum toxin treatment?
- Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial.
- A prospective trial of fungal colonization after laser resurfacing of the face: correlation between culture positivity and symptoms of pruritus.
- Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser.
- Evaluation of the role of exogenous estrogen in postoperative progress after laser Skin resurfacing.
- Nonablative laser and light treatments: histology and tissue effects--a review.
- Lasers in facial plastic surgery.
- Botulinum a exotoxin for hyperfunctional facial lines: where not to inject.
- My Skin has become drier and more fragile as I've aged. Why is that, and what can I do about it?
- Glycolic acid peels compared to microdermabrasion: a right-left controlled trial of efficacy and patient satisfaction.
- Rapid development of nonmelanoma Skin cancer after CO2 laser resurfacing.
- Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlle...
- Scar management: keloid, hypertrophic, atrophic, and acne scars.
- Leg vein management: sclerotherapy, ambulatory phlebectomy, and laser surgery.
- Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases.
- Laser surgery of leg veins.
- Near-infrared laser adjuvant for influenza vaccine.
Schools
University Of Ottawa Faculty Of Medicine
Sunnybrook Hospital
St Johns Hospital
University Toronto
Havard MedMass Genl Hosps
Procedures Preformed
- Dermal Filler
- Destruction of Benign Skin Lesion
- Laser Tattoo Removal
- Non-Cosmetic Chemodenervation
Conditions Treated
- Actinic Keratosis
- Atopic Dermatitis (Eczema)
- Basal Cell Carcinoma
- Benign Skin Lesion
- View All
Doctors Specialties
- Cosmetic Dermatology
- Dermatology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Boston Now Newspaper
- Boston Herald
- Fellow (FAAD)
- Fellow (FASDS)
- Super Doctor
- Top MD
Education
-
Beth Israel Deaconess Medical Center -
University of Ottawa Faculty of Medicine
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1316909005 | |
| NPPES Provider LastName | DOVER | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 024672116 | |
| NPPES Provider State | MA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 96.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316909005 |
| Last Name Of The Provider | DOVER |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
Dr. Michael S. Kaminer, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth A. Arndt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laurel M. Morton, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan A. Selkin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas E. Rohrer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Karen H. Kim, MD |
|
Dr. Brooke C. Sikora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura S. Winterfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonid Izikson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine Liang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manisha Thakuria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah A. Scott, MD
This Doctor is OpenDoctor Recommended.
|